There is growing evidence on the association between cancer and atrial fibrillation (AFib). To educate the medical community about the importance of assessing risk, monitoring, and managing AFib and other cardiovascular risk factors for oncology patients, the ACC created the Managing AFib and BTK Inhibitors: Balancing Risk online course. Review important topics such as patient-specific risk factors, antiplatelet activity of BTK inhibitors and drug-drug interactions, as well as the steps to anticoagulation and dosing requirements in different CLL patients with this interactive infographic – Anticoagulation for AFib in Patients Receiving BTK Inhibitors. Stay up to date on best practices to guide clinical decision-making and improve management of patients with AFib and cancer with the Managing AFib and BTK Inhibitors: Balancing Risk online course.